[1]
|
Moza, B., Varma, A.K., Buonpane, R.A., Zhu, P., Herfst, C.A., et al. (2007) Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. EMBO Journal, 26, 1187-1197.
doi:10.1038/sj.emboj.7601531
|
[2]
|
Watkins, S.L. and Pichler, W.J. (2013) Activating interactions of sulfanilamides with T cell receptors. Open Journal of Immunology, 3, in press.
|
[3]
|
Engler, O.B., Strasser, I., Naisbitt, D.J., Cerny, A. and Pichler, W.J. (2004) A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. Toxicology, 197, 47-56.
doi:10.1016/j.tox.2003.12.008
|
[4]
|
Ko, T.M., Chung, W.H., Wei, C.Y., Shih, H.Y., Chen, J.K., et al. (2011) Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. Journal of Allergy and Clinical Immunology, 128, 1266-1276.
|
[5]
|
Komatsu, T., Moriya, N. and Shiohara, T. (1996) T cell receptor (TCR) repertoire and function of human epidermal T cells: Restricted TCR V alpha-V beta genes are utilized by T cells residing in the lesional epidermis in fixed drug eruption. Clinical & Experimental Immunology, 104, 343-350.
doi:10.1046/j.1365-2249.1996.30738.x
|
[6]
|
Sumida, T., Kita, Y., Yonaha, F., Maeda, T., Iwamoto, I., et al. (1994) T cell receptor V alpha repertoire of infiltrating T cells in labial salivary glands from patients with Sjogren’s syndrome. Journal of Rheumatology, 21, 1655- 1661.
|
[7]
|
Sumida, T., Yonaha, F., Maeda, T., Tanabe, E., Koike, T., et al. (1992) T cell receptor repertoire of infiltrating T cells in lips of Sjogren’s syndrome patients. Journal of Clinical Investigation, 89, 681-685.
doi:10.1172/JCI115635
|
[8]
|
Wucherpfennig, K.W. and Hafler, D.A. (1995) A review of T-cell receptors in multiple sclerosis: Clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide. Annals of the New York Academy of Sciences, 756, 241-258.
doi:10.1111/j.1749-6632.1995.tb44522.x
|
[9]
|
He, X., Rosloniec, E.F., Myers, L.K., McColgan, W.L., Gumanovskaya, M., et al. (2004) T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage. Arthritis & Rheumatism, 50, 1996-2004. doi:10.1002/art.20289
|
[10]
|
Thompson, S.D., Murray, K.J., Grom, A.A., Passo, M.H., Choi, E., et al. (1998) Comparative sequence analysis of the human T cell receptor beta chain in juvenile rheumatoid arthritis and juvenile spondylarthropathies: Evidence for antigenic selection of T cells in the synovium. Arthritis & Rheumatism, 41, 482-497.
doi:10.1002/1529-0131(199803)41:3<482::AID-ART15>3.0.CO;2-G
|
[11]
|
Lopez-Sagaseta, J., Dulberger, C.L., Crooks, J.E., Parks, C.D., Luoma, A.M., et al. (2013) The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. Proceedings of the National Academy of Sciences of USA, 110, E1771-1778.
doi:10.1073/pnas.1222678110
|
[12]
|
Reantragoon, R., Kjer-Nielsen, L., Patel, O., Chen, Z., Illing, P.T., et al. (2012) Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. Journal of Experimental Medicine, 209, 761-774. doi:10.1084/jem.20112095
|
[13]
|
Pichler, W.J. (2003) Delayed drug hypersensitivity reactions. Annals of Internal Medicine, 139, 683-693.
doi:10.7326/0003-4819-139-8-200310210-00012
|
[14]
|
Garcia-Carrasco, M., Fuentes-Alexandro, S., Escarcega, R.O., Salgado, G., Riebeling, C., et al. (2006) Pathophysiology of Sjogren’s syndrome. Archives of Medical Research, 37, 921-932. doi:10.1016/j.arcmed.2006.08.002
|
[15]
|
de Bakker, P.I., McVean, G., Sabeti, P.C., Miretti, M.M., Green, T., et al. (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nature Genetics, 38, 1166-1172.
doi:10.1038/ng1885
|
[16]
|
Wei, C.Y., Chung, W.H., Huang, H.W., Chen, Y.T. and Hung, S.I. (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens- Johnson syndrome. Journal of Allergy and Clinical Immunology, 129, 1562-1569.
|
[17]
|
Yang, C.W., Hung, S.I., Juo, C.G., Lin, Y.P., Fang, W.H., et al. (2007) HLA-B*1502-bound peptides: Implications for the pathogenesis of carbamazepine-induced Stevens- Johnson syndrome. Journal of Allergy and Clinical Immunology, 120, 870-877. doi:10.1016/j.jaci.2007.06.017
|
[18]
|
Hart, B.A., Hintzen, R.Q. and Laman, J.D. (2009) Multiple sclerosis: A response-to-damage model. Trends in Molecular Medicine, 15, 235-244.
|
[19]
|
Wei, C.Y., Ko, T.M., Shen, C.Y. and Chen, Y.T. (2012) A recent update of pharmacogenomics in drug-induced severe skin reactions. Drug Metabolism and Pharmacokinetics, 27, 132-141.
doi:10.2133/dmpk.DMPK-11-RV-116
|
[20]
|
Adam, J., Pichler, W.J. and Yerly, D. (2011) Delayed drug hypersensitivity: Models of T-cell stimulation. British Journal of Clinical Pharmacology, 71, 701-707.
doi:10.1111/j.1365-2125.2010.03764.x
|
[21]
|
Pichler, W.J., Beeler, A., Keller, M., Lerch, M., Posadas, S., et al. (2006) Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergology International, 55, 17-25. doi:10.2332/allergolint.55.17
|
[22]
|
von Greyerz, S., Zanni, M.P., Frutig, K., Schnyder, B., Burkhart, C., et al. (1999) Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta + T cell clones. Journal of Immunology, 162, 595-602.
|
[23]
|
Yamamoto, T., Katayama, I. and Nishioka, K. (1998) Analysis of T cell receptor Vbeta repertoires of annular erythema associated with Sjogren’s syndrome. European Journal of Dermatology, 8, 248-251.
|
[24]
|
McArthur, C.P., Daniels, P.J., Kragel, P., Howard, P.F. and Julian, L. (1997) Sjogren’s syndrome salivary gland immunopathology: Increased laminin expression precedes lymphocytic infiltration. Journal of Autoimmunity, 10, 59-65. doi:10.1006/jaut.1996.0109
|
[25]
|
Miceli-Richard, C., Gestermann, N., Ittah, M., Comets, E., Loiseau, P., et al. (2009) The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjogren’s syndrome. Arthritis & Rheumatism, 60, 1991-1997. doi:10.1002/art.24662
|
[26]
|
Nordmark, G., Kristjansdottir, G., Theander, E., Eriksson, P., Brun, J.G., et al. (2009) Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren’s syndrome. Genes & Immunity, 10, 68-76.
doi:10.1038/gene.2008.94
|
[27]
|
Di Virgilio, F., Boeynaems, J.M. and Robson, S.C. (2009) Extracellular nucleotides as negative modulators of immunity. Current Opinion in Pharmacology, 9, 507-513.
doi:10.1016/j.coph.2009.06.021
|
[28]
|
Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J.M., et al. (2001) Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood, 97, 587-600. doi:10.1182/blood.V97.3.587
|
[29]
|
Duhant, X., Schandene, L., Bruyns, C., Gonzalez, N.S., Goldman, M., et al. (2002) Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes. Journal of Immunology, 169, 15-21.
doi:10.1002/med.20067
|
[30]
|
Alonso, H., Bliznyuk, A.A. and Gready, J.E. (2006) Combining docking and molecular dynamic simulations in drug design. Medicinal Research Reviews, 26, 531-568.
doi:10.1002/med.20067
|
[31]
|
Cichero, E., D'Ursi, P., Moscatelli, M., Bruno, O., Orro, A., et al. (2013) Homology modeling, docking studies and molecular dynamic simulations using GPU architecture to probe the type-11 Phosphodiesterase (PDE11) catalytic site: A computational approach for the rational design of selective inhibitors. Chemical Biology & Drug Design.
|
[32]
|
Arnold, K., Bordoli, L., Kopp, J. and Schwede, T. (2006) The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics, 22, 195-201.
doi:10.1093/bioinformatics/bti770
|
[33]
|
Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A.E., et al. (2005) GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701-1718. doi:10.1002/jcc.20291
|
[34]
|
Oostenbrink, C., Soares, T.A., van der Vegt, N.F. and van Gunsteren, W.F. (2005) Validation of the 53A6 GROMOS force field. European Biophysics Journal, 34, 273-284.
doi:10.1007/s00249-004-0448-6
|
[35]
|
von Greyerz, S., Bultemann, G., Schnyder, K., Burkhart, C., Lotti, B., et al. (2001) Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones. International Immunology, 13, 877-885.
doi:10.1093/intimm/13.7.877
|
[36]
|
Seeliger, D and de Groot, B.L. (2010) Ligand docking and binding site analysis with PyMOL and Autodock/ Vina. Journal of Computer-Aided Molecular Design, 24, 417-422. doi:10.1007/s10822-010-9352-6
|
[37]
|
Trott, O. and Olson, A.J. (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455-461.
|
[38]
|
Criscitiello, M.F., Ohta, Y., Saltis, M., McKinney, E.C. and Flajnik, M.F. (2010) Evolutionarily conserved TCR binding sites, identification of T cells in primary lymphoid tissues, and surprising trans-rearrangements in nurse shark. The Journal of Immunology, 184, 6950-6960.
doi:10.4049/jimmunol.0902774
|
[39]
|
Dzik, J.M. (2010) The ancestry and cumulative evolution of immune reactions. Acta Biochimica Polonica, 57, 443- 466.
|
[40]
|
Mikami, T., Miyashita, H., Takatsuka, S., Kuroki, Y. and Matsushima, N. (2012) Molecular evolution of vertebrate Toll-like receptors: Evolutionary rate difference between their leucine-rich repeats and their TIR domains. Gene, 503, 235-243. doi:10.1016/j.gene.2012.04.007
|
[41]
|
Posadas, S.J. and Pichler, W.J. (2007) Delayed drug hypersensitivity reactions-new concepts. Clinical & Experimental Allergy, 37, 989-999.
doi:10.1111/j.1365-2222.2007.02742.x
|
[42]
|
Naisbitt, D.J., Britschgi, M., Wong, G., Farrell, J., Depta, J.P., et al. (2003) Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Molecular Pharmacology, 63, 732-741.
|
[43]
|
Mauri-Hellweg, D., Bettens, F., Mauri, D., Brander, C., Hunziker, T., et al. (1995) Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. Journal of Immunology, 155, 462-472.
|
[44]
|
Murata, H., Kita, Y., Sakamoto, A., Matsumoto, I., Matsumura, R., et al. (1995) Limited TCR repertoire of infiltrating T cells in the kidneys of Sjogren’s syndrome patients with interstitial nephritis. Journal of Immunology, 155, 4084-4089.
|
[45]
|
Miah, M.A., Ahmed, S.S., Chowdhury, S.A., Begum, F. and Rahman, S.H. (2008) Fixed drug eruptions due to cotrimoxazole. Mymensingh Medical Journal, 17, S1-S5.
|
[46]
|
Taqi, S.A., Zaki, S.A., Nilofer, A.R. and Sami, L.B. (2012) Trimethoprim-sulfamethoxazole-induced Steven Johnson syndrome in an HIV-infected patient. Indian Journal of Pharmacology, 44, 533-535.
doi:10.4103/0253-7613.99346
|
[47]
|
Vandenbark, A.A., Culbertson, N.E., Bartholomew, R.M., Huan, J., Agotsch, M., et al. (2008) Therapeutic vaccinetion with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis. Immunology, 123, 66- 78. doi:10.1111/j.1365-2567.2007.02703.x
|
[48]
|
de Haan, E.C., Moret, E.E., Wagenaar-Hilbers, J.P., Liskamp, R.M. and Wauben, M.H. (2005) Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy. Molecular Immunology, 42, 365-373. doi:10.1016/j.molimm.2004.07.015
|